17. 促進法規協和與合作之國際組織
ICH ( established in 1990 ) PIC/S ( established in
The International 1995 )
Conference on 全名 The Pharmaceutical
Harmonization of Inspection Convention and
Technical Requirements for Pharmaceutical Inspection
the Registration of Co-operation Scheme
Pharmaceuticals for 現有 37 成員( Health
Human Use Authorities ),分屬 35 國
6 個固定成員 家,包括 28 個歐洲國家、
歐: EC 、 EFPIA 加拿大、阿根廷、南非、以
美: FDA 、 PhRMA 色列、澳洲、新加坡、馬來
日: MHLW 、 JPMA 西亞,會員持續增加中。
ICH Observers : WHO 、 Partners :
EFTA 、 Health Canada EMA 、 EDQM 、 WHO
、 UNICEF
PIC/S GMP Guide 相當於
歐盟 GMP
10/19/12 GMP Inspectorate TFDA 17
24. PIC/S GMP
PIC/S GMP 規範第一章原則「製造許可的持有者,應依
照核發之上市許可要求來製造藥品,以避免因品質不佳
或療效欠佳而使病人陷於危險」
Good Manufacturing Practice is that part of Quality
Assurance which ensures that products are consistently
produced and controlled to the quality standards
appropriate to their intended use and as required by the
marketing authorization or product specification.
確保藥品能被持續穩定地生產與管制,以達到適
合其預定效用及上市許可或產品規格所要求之品
質標準
10/19/12 GMP Inspectorate TFDA 24
56. 結語
To be the world class
TFD
A
The Quality Journey is a
Voyage, NOT a Destination!
We’re Committed to our
Quality Journey GM
Ins P
pec
tor
at e
10/19/12 GMP Inspectorate TFDA 56
Industry’s becoming more international and seeking new global markets Harmonization of regulatory
European Commission - European Union (EU) The European Commission represents the 27 members of the EU. The Commission works through harmonisation of legislation and technical requirements and procedures, to achieve a single market in pharmaceuticals to allow free movement of products throughout the EU. The European Medicines Agency (EMEA) has been established by the Commission and is situated in London. Technical and scientific support for ICH activities is provided by the Committee for Medicinal Products for Human Use (CHMP) of the EMEA. European Federation of Pharmaceutical Industries and Associations (EFPIA) EFPIA, is situated in Brussels and has, as its members, 29 national pharmaceutical industry associations and 45 leading pharmaceutical companies involved in the research, development and manufacturing of medicinal products in Europe for human use. Much of the Federation's work is concerned with the activities of the European Commission and the EMEA. A wide network of experts and country coordinators has been established, through Member Associations, to ensure that EFPIA's views within ICH are representative of the European industry. Ministry of Health, Labour and Welfare, Japan (MHLW) The Ministry of Health, Labour and Welfare has responsibilities for approval and administration of drugs, medical devices and cosmetics in Japan. Technical and scientific support for ICH activities are provided by the Pharmaceuticals and Medical Devices Agency (PMDA) (which was established in April 2004 as a new administrative agency for scientific review for drug approval), and by the National Institute of Health Sciences (NIHS) and other experts from academia. Japan Pharmaceutical Manufacturers Association (JPMA) JPMA represents 75 members (including 20 foreign affiliates) and 14 committees. Membership includes all the major research-based pharmaceutical manufacturers in Japan. ICH work is coordinated through specialised committees of industry experts who also participate in the Expert Working Groups. Among the objectives of JPMA is the development of a competitive pharmaceutical industry with a greater awareness and understanding of international issues. JPMA promotes and encourages the adoption of international standards by its member companies. US Food and Drug Administration (FDA) The US Food and Drug Administration has a wide range of responsibilities for drugs, biologicals, medical devices, cosmetics and radiological products. The largest of the world's drug regulatory agencies FDA is responsible for the approval of all drug products used in the USA. The FDA consists of administrative, scientific and regulatory staff organised under the Office of the Commissioner and has several Centers with responsibility for the various products which are regulated. Technical advice and experts for ICH work are drawn from the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). Pharmaceutical Research and Manufacturers of America (PhRMA) The Pharmaceutical Research and Manufacturers of America - PhRMA - represents the research-based industry in the USA. The Association has 67 companies in membership which are involved in the discovery, development and manufacture of prescription medicines. There are also 24 research affiliates which conduct biological research related to the development of drugs and vaccines. PhRMA, which was previously known as the US Pharmaceutical Manufacturers Association (PMA), coordinates its technical input to ICH through its Scientific and Regulatory Section. Special committees have been set up, of experts from PhRMA companies, to deal with ICH topics. EMEA ( European Medicines Agency )及 EDQM ( European Directorate for the Quality of Medicines & HealthCare ),以及 WHO ( World Health Organization )與 UNICEF ( United Nations International Children’s Emergency Fund )皆與 PIC/S 簽署合作協議,並以合作夥伴( partners )身分出席 PIC/S 會員大會
Ministry of Health of Iran and the Bureau of Food and Drugs of the Philippines